Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 295

1.

Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know.

Vincent JL, Castro P, Hunt BJ, Jörres A, Praga M, Rojas-Suarez J, Watanabe E.

Crit Care. 2018 Jun 13;22(1):158. doi: 10.1186/s13054-018-2073-2. No abstract available.

2.

Eculizumab as a treatment for atypical hemolytic syndrome secondary to carfilzomib.

Moliz C, Gutiérrez E, Cavero T, Redondo B, Praga M.

Nefrologia. 2018 Apr 28. pii: S0211-6995(18)30042-0. doi: 10.1016/j.nefro.2018.02.005. [Epub ahead of print] English, Spanish. No abstract available.

3.

IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?

Praga M, Caravaca F, Yuste C, Cavero T, Hernández E, Morales E, Mérida E, Moreno JA, Sevillano A, Gutiérrez E.

Nefrologia. 2018 Apr 7. pii: S0211-6995(18)30037-7. doi: 10.1016/j.nefro.2018.01.001. [Epub ahead of print] English, Spanish. No abstract available.

4.

[Cardiovascular disease in lupus nephritis: An underestimated risk].

Caravaca-Fontán F, Praga M.

Hipertens Riesgo Vasc. 2018 Apr - Jun;35(2):51-53. doi: 10.1016/j.hipert.2018.02.003. Epub 2018 Mar 8. Spanish. No abstract available.

PMID:
29526670
5.

Heyde syndrome: Correction of anemia after aortic valve replacement in a hemodialysis patient.

Milla M, Hernández E, Mérida E, Yuste C, Rodríguez P, Praga M.

Nefrologia. 2018 May - Jun;38(3):327-329. doi: 10.1016/j.nefro.2017.05.002. Epub 2018 Mar 6. English, Spanish. No abstract available.

6.

Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.

Marco H, Draibe J, Villacorta J, Quintana LF, Martin N, Garcia-Osuna R, Cabre C, Martín-Gómez MA, Balius A, Saurina A, Picazo M, Gich-Saladich I, Navarro-Díaz M, Praga M, Cavero T, Ballarin J, Díaz-Encarnación MM; Spanish Group for the Study of Glomerular Disease (GLOSEN).

Clin Rheumatol. 2018 Apr;37(4):1065-1074. doi: 10.1007/s10067-017-3973-2. Epub 2018 Mar 9.

PMID:
29520673
7.

Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up in a single-center cohort study.

Fernández-Ruiz M, Polanco N, García-Santiago A, Muñoz R, Hernández AM, González E, Mercado VR, Fernández I, Aguado JM, Praga M, Andrés A.

Transpl Int. 2018 Jan 22. doi: 10.1111/tri.13118. [Epub ahead of print]

PMID:
29356211
8.

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.

Cruzado JM, Lauzurica R, Pascual J, Marcen R, Moreso F, Gutierrez-Dalmau A, Andrés A, Hernández D, Torres A, Beneyto MI, Melilli E, Manonelles A, Arias M, Praga M.

Kidney Int Rep. 2017 Sep 28;3(1):122-132. doi: 10.1016/j.ekir.2017.08.016. eCollection 2018 Jan.

9.

Hyperkalemia of non-renal origin in a hemodialysis patient.

Rodríguez P, Mérida E, Hernández E, Milla M, Praga M.

Nefrologia. 2018 Jan - Feb;38(1):96-97. doi: 10.1016/j.nefro.2017.01.005. English, Spanish. No abstract available.

10.

Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease.

Urrestarazú A, Otatti G, Silvariño R, Garau M, Coitiño R, Alvarez A, Gonzalez E, Gadola L, Praga M, Noboa O.

Kidney Int Rep. 2017 Jun 16;2(5):905-912. doi: 10.1016/j.ekir.2017.05.011. eCollection 2017 Sep.

11.

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.

Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J; Focal Segmental Glomerulosclerosis Study Group.

Kidney Int Rep. 2017 Apr 7;2(5):800-810. doi: 10.1016/j.ekir.2017.03.011. eCollection 2017 Sep.

12.

Nephropathology and nephrology. The need for a change.

Vazquez Martul E, Praga M.

Nefrologia. 2018 May - Jun;38(3):247-249. doi: 10.1016/j.nefro.2017.11.002. Epub 2017 Dec 8. English, Spanish. No abstract available.

13.

Podocytes are new cellular targets of haemoglobin-mediated renal damage.

Rubio-Navarro A, Sanchez-Niño MD, Guerrero-Hue M, García-Caballero C, Gutiérrez E, Yuste C, Sevillano Á, Praga M, Egea J, Román E, Cannata P, Ortega R, Cortegano I, de Andrés B, Gaspar ML, Cadenas S, Ortiz A, Egido J, Moreno JA.

J Pathol. 2018 Mar;244(3):296-310. doi: 10.1002/path.5011. Epub 2018 Jan 10.

PMID:
29205354
14.

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study.

Luño J, Varas J, Ramos R, Merello I, Aljama P, MartinMalo A, Pascual J, Praga M; ORD Group.

Kidney Int Rep. 2017 Mar 7;2(4):665-675. doi: 10.1016/j.ekir.2017.03.001. eCollection 2017 Jul.

15.

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option.

Román E, Mendizábal S, Jarque I, de la Rubia J, Sempere A, Morales E, Praga M, Ávila A, Górriz JL.

Nefrologia. 2017 Sep - Oct;37(5):478-491. doi: 10.1016/j.nefro.2017.01.006. English, Spanish.

16.

Monoclonal gammopathies of renal significance.

Caravaca-Fontán F, Gutiérrez E, Delgado Lillo R, Praga M.

Nefrologia. 2017 Sep - Oct;37(5):465-477. doi: 10.1016/j.nefro.2017.03.012. English, Spanish.

17.

A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.

Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.

Kidney Int. 2018 Feb;93(2):450-459. doi: 10.1016/j.kint.2017.06.022. Epub 2017 Sep 12.

PMID:
28911789
18.

Gastrointestinal complications induced by sevelamer crystals.

Yuste C, Mérida E, Hernández E, García-Santiago A, Rodríguez Y, Muñoz T, Gómez GJ, Sevillano Á, Praga M.

Clin Kidney J. 2017 Aug;10(4):539-544. doi: 10.1093/ckj/sfx013. Epub 2017 Apr 10.

19.

Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches.

Guerrero-Hue M, Rubio-Navarro A, Sevillano Á, Yuste C, Gutiérrez E, Palomino-Antolín A, Román E, Praga M, Egido J, Moreno JA.

Nefrologia. 2018 Jan - Feb;38(1):13-26. doi: 10.1016/j.nefro.2017.05.009. Epub 2017 Jun 28. English, Spanish.

20.

Cortical necrosis: An uncommon cause of acute renal failure with a very poor outcome.

Rodríguez PM, Morales E, Sánchez Á, Milla M, Martínez MA, Praga M.

Nefrologia. 2017 May - Jun;37(3):339-341. doi: 10.1016/j.nefro.2016.10.017. English, Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center